Real-world Analysis of Workup at Disease Progression and Implementation of Osimertinib for EGFR+ NSCLC
NCT04105153
·
clinicaltrials.gov ↗
COMPLETED
Status
400
Enrollment
OTHER
Sponsor class
Conditions
EGFR Positive Non-small Cell Lung Cancer
Sponsor
Thoraxklinik-Heidelberg gGmbH
Collaborators
[object Object]